If you receive JavaScript required to sign in error message when using Skype, OneDrive, Teams or any other program, you need to turn on or enable JavaScript in your ...

It's only a matter of time before your website crashes. Follow these backup tips to avoid losing precious data. In 2014, I began my career at PCMag as a freelancer. That blossomed into a full-time ...

Katherine Haan, MBA, is a Senior Staff Writer for Forbes Advisor and a former financial advisor turned international bestselling author and business coach. For more than a decade, she’s helped small ...

While incognito mode in any of the big four web browsers offers a measure of privacy, it doesn’t completely hide your tracks online. Here’s how the feature works ...

Connecticut lawmakers and supporters are again discussing a long-debated proposal to build a bridge connecting Connecticut and Long Island, a project advocates say could cut travel times and ease ...

Learn the common mistakes of using one Apple Account on multiple iPhones, including iCloud syncing, Messages, FaceTime, Find My, and security risks. Using the same Apple Account on multiple iPhones ...

Rachel Williams has been an editor for nearly two decades. She has spent the last five years working on small business content to help entrepreneurs start and grow their businesses. She’s well-versed ...

When social media platforms first emerged, they were pitched as tools for connection—as a way to stay in touch with friends, share photos, and keep up with people you'd otherwise lose track of.

The rise of NSFW AI character chat sites in the last several years, especially those designed to simulate romantic or erotic connections, signals more than just a shift in how we relate to technology, ...

A better system for understanding the real value of happy customers by Fred Reichheld, Darci Darnell and Maureen Burns From the Magazine (November–December 2021) On ...

Lessons from the life sciences by Noubar Afeyan and Gary P. Pisano On November 30, 2020, Moderna Therapeutics announced that Phase III clinical trials for its messenger RNA vaccine demonstrated 95% ...